🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and immunogenicity of high-titered ALVAC-HIV MN120TM...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000847
Treatments Being Tested
To evaluate the safety and immunogenicity of ALVAC-HIV MN120TMG (vCP205) in...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001055
Treatments Being Tested
The purpose of this study is to find out whether three different anti-HIV v...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000904
To evaluate the safety and immunogenicity of an accelerated schedule of rec...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001076
Treatments Being Tested
The purpose of this study is to test three experimental HIV vaccines. This ...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000946
To evaluate, in HIV-negative volunteers, the safety and immunogenicity of A...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00001072
Treatments Being Tested
The purpose of this study is to see if it is safe to give ALVAC-HIV vCP205,...
Status
Completed
Location
UVRI - IAVI HIV Vaccine Program
Start Date
TBD
Trial ID
NCT00007423
Treatments Being Tested
To compare the safety of ALVAC-HIV vCP205 to that of ALVAC-RG vCP65 rabies ...
Status
Completed
Location
UAB AVEG
Start Date
TBD
Trial ID
NCT00000884
Part A: To evaluate the safety and immunogenicity of ALVAC vCP125 HIV-1 gp1...
Status
Completed
Location
JHU AVEG
Start Date
TBD
Trial ID
NCT00000813
Treatments Being Tested